Manji MF - Search Results

1

Positron emission tomography for the evaluation of metastases in patients with carcinoma of the cervix: a retrospective review.

Kerr IG, Manji MF, Powe J, Bakheet S, Al Suhaibani H, Subhi J. Kerr IG, et al. Among authors: manji mf. Gynecol Oncol. 2001 Jun;81(3):477-80. doi: 10.1006/gyno.2001.6166. Gynecol Oncol. 2001. PMID: 11371141

2

Carcinoma of cervix, the King Faisal Specialist Hospital & Research Center experience--the need for screening for cervical cancer in developing countries.

Manji MF, Pradhan D, El-Senoussi M, Bakri Y, Subhi J, Ezzat A, Zwan F, Ramirez C. Manji MF, et al. Eur J Gynaecol Oncol. 1999;20(5-6):412-5. Eur J Gynaecol Oncol. 1999. PMID: 10609508

3

Pericardial metastasis in carcinoma of the uterine cervix.

Jamshed A, Khafaga Y, El-Husseiny G, Gray AJ, Manji M. Jamshed A, et al. Gynecol Oncol. 1996 Jun;61(3):451-3. doi: 10.1006/gyno.1996.0174. Gynecol Oncol. 1996. PMID: 8641633 Review.

4

Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide.

Hoskins PJ, Wong F, Swenerton KD, Pike JA, Manji M, McMurtrie E, Acker B, Le Riche J. Hoskins PJ, et al. Gynecol Oncol. 1995 Feb;56(2):218-25. doi: 10.1006/gyno.1995.1035. Gynecol Oncol. 1995. PMID: 7896189 Clinical Trial.

5

Female circumcision (female genital mutilation): a problem for brachytherapy in cervical cancer.

Manji MF, Al Badawi I, El Enbaby A, Al Bareedy N. Manji MF, et al. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):675-80. doi: 10.1111/j.1525-1438.2006.00398.x. Int J Gynecol Cancer. 2006. PMID: 16681746

6

Carcinoid tumour of the gastrointestinal tract: prognostic factors and disease outcome.

Agranovich AL, Anderson GH, Manji M, Acker BD, Macdonald WC, Threlfall WJ. Agranovich AL, et al. J Surg Oncol. 1991 May;47(1):45-52. doi: 10.1002/jso.2930470111. J Surg Oncol. 1991. PMID: 1708841

7

The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971-1988.

Newman G, Calverley DC, Acker BD, Manji M, Hay J, Flores AD. Newman G, et al. Radiother Oncol. 1992 Nov;25(3):196-202. doi: 10.1016/0167-8140(92)90268-y. Radiother Oncol. 1992. PMID: 1470696

8

'Moderate-risk' ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation.

Hoskins PJ, Swenerton KD, Manji M, Wong F, O'Reilly SE, McMurtrie EJ, Le N, Acker B, Le Richer J. Hoskins PJ, et al. Int J Gynecol Cancer. 1994 Jul;4(4):272-278. doi: 10.1046/j.1525-1438.1994.04040272.x. Int J Gynecol Cancer. 1994. PMID: 11578417

9

Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in 'high-risk' epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade).

Hoskins PJ, Swenerton KD, Wong F, Manji MF, McMurtrie EM, Le N, Pike J. Hoskins PJ, et al. Among authors: manji mf. Int J Gynecol Cancer. 1995 Mar;5(2):134-142. doi: 10.1046/j.1525-1438.1995.05020134.x. Int J Gynecol Cancer. 1995. PMID: 11578468

10

Internal mammary lymphoscintigraphy in breast carcinoma: possible significance in relation to current treatment.

Manji MF. Manji MF. J Can Assoc Radiol. 1982 Mar;33(1):10-4. J Can Assoc Radiol. 1982. PMID: 7076699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters